The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Open accessAbstract
The permeability of insulin (Ins), nerve growth factor (NGF), albumin (Alb), transferrin (Trf), and IgG across the blood-nerve barrier (BNB) and blood-brain barrier (BBB) in normal adult rats was quantified by measuring the (permeability coefficient x surface area) product (PS) with the i.v. bolus-injection technique in the cannulated brachial vein and artery using radioiodinated proteins. The PS values of the BNB for IgG and Alb were low: 0.079 +/- 0.029 x 10(-6) and 0.101 +/- 0.088 x 10(-6) ml.g-1.s-1, (mean +/- SD, respectively). The PS values for NGF and Trf were 16.1-fold and 25.5-fold higher than for Alb. The PS for Ins across the BNB was 33.190 +/- 2.053 x 10(-6) ml.g-1.s-1--a remarkable 329-fold increase compared with Alb. The PS values of the BBB for IgG and Alb in different brain regions were all low, from 0.028 +/- 0.017 to 0.151 +/- 0.035 x 10(-6) ml.g-1.s-1 (mean +/- SD). NGF and Trf had comparable PS values from 13- to 32-fold higher than for Alb, except for the brain stem, where the PS for Trf was 66-fold higher than for Alb. The mean PS for Ins across the BBB ranged from 15.78 +/- 5.45 x 10(-6) ml.g-1.s-1 for the cortex to 22.62 +/- 7.50 x 10(-6) ml.g-1.s-1 for the brain stem--again a remarkable 105- to 390-fold increase relative to Alb. Because reliable PS measurements were obtained for all proteins tested, the BBB and BNB cannot be considered impermeable to proteins--a concept that has plagued brain- and nerve-barrier research. The low PS values for IgG and Alb indicate low rates of transfer; however, Alb, in particular, is the major protein of endoneurial and ventricular fluid, which suggests that these PS values may be significant. Ins had the highest PS values, which likely reflect the mechanism of transport across the barriers--that is, receptor-mediated transport. Because NGF and Trf had PS values 13- to 66-fold higher than for Alb, whether this reflects receptor-mediated uptake, adsorptive-mediated transcytosis, or some other mechanism is unclear. That the PS values for NGF and Trf differ from Alb and IgG clearly suggests, however, a different uptake mechanism. Finally, the remarkably high PS values for Ins across the BBB and BNB identify this protein and its putative receptor on capillary endothelial cells as a potential target for drug delivery into the central and peripheral nervous systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“mAbs exhibit limited distribution to the brain, and mAb concentrations was determined to be 0.1–0.2 % and 0.02 % of the steady‐state circulating mAb concentration in rodents and cynomolgus monkey, respectively.92, 93”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
In the citing paper
“the PK of the anti‐Her2/CD3T cell‐dependent bispecific (TDB) antibody in rats demonstrated similar clearance and half‐life as trastuzumab.92”
From Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development (2018) · cites this paper as [92]
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C., & Porte, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 808
An immunohistochemical study of the nerve growth factor receptor in developing rats
Yan, Q., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-09-03481.1988 · Cited by 605
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 550
Taniuchi, M., Clark, H., Schweitzer, J. B., & Johnson, E. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00664.1988 · Cited by 542
Receptor-Mediated Transport of Insulin Across Endothelial Cells
King, G. L., & Johnson, S. M. (1985) · Science · doi:10.1126/science.3883490 · Cited by 474
Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
Ohno, K., Pettigrew, K. D., & Рапопорт, С. И. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.235.3.h299 · Cited by 454
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 410
Flagged first, then by citations
1 of the 82 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity
Kadry, H., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00230-3 · Cited by 1,853
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A. G., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 871
Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain
Carro, E., Nuñez, A., Busiguina, S., & Torres-Aleman, I. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02926.2000 · Cited by 762
The blood–brain barrier in health and disease: Important unanswered questions
Profaci, C. P., Munji, R. N., Pulido, R. S., & Daneman, R. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190062 · Cited by 811
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
Watkins, L. R., & Maier, S. F. (2002) · Physiological Reviews · doi:10.1152/physrev.00011.2002 · Cited by 733
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622
Poduslo, J. F., & Curran, G. L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00250-v · Cited by 614
Self-citationCampylobacter Species and Guillain-Barre Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. W. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 591
Insulin in the brain: There and back again
Banks, W. A., Owen, J. B., & Erickson, M. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.006 · Cited by 593
Physiological blood–brain transport is impaired with age by a shift in transcytosis
Yang, A. C., Stevens, M. Y., Chen, M. B., Lee, D. P., Stähli, D., Gate, D., Contrepois, K., Chen, W., Iram, T., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2453-z · Cited by 477
Binding of transition metal ions to albumin: Sites, affinities and rates
Bal, W., Sokołowska, M., Kurowska, E., & Faller, P. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.018 · Cited by 495
Delivery of Neurotrophic Factors to the Central Nervous System: Pharmacokinetic Considerations
Thorne, R. G., & Frey, W. H. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140120-00003 · Cited by 487
Bohrmann, B., Baumann, K., Benz, J., Gerber, F., Huber, W., Knoflach, F., Messer, J., Oroszlan, K., Rauchenberger, R., Richter, W. F., et al. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110977 · Cited by 448
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Zheng, Q., & Wang, X. (2024) · Protein & Cell · doi:10.1093/procel/pwae026 · Cited by 483
Marsh, S. E., Abud, E. M., Lakatos, A., Karimzadeh, A., Yeung, S. T., Davtyan, H., Fote, G. M., Lau, L., Weinger, J. G., Lane, T. E., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525466113 · Cited by 411
Kariolis, M. S., Wells, R. C., Getz, J. A., Kwan, W., Mahon, C. S., Tong, R. K., Kim, D. J., Srivastava, A., Bédard, C., Henne, K. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1359 · Cited by 362
Matrices and scaffolds for protein delivery in tissue engineering
Teßmar, J., & Göpferich, A. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.020 · Cited by 352
Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430
Pardridge, W. M., Kang, Y., Buciak, J. L., & Yang, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016244500596 · Cited by 324
Improving influence of insulin on cognitive functions in humans
Kern, W., Peters, A., Fruehwald-Schultes, B., Deininger, E., Born, J., & Fehm, H. L. (2001) · Neuroendocrinology · doi:10.1159/000054694 · Cited by 308
Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development
Ovacik, M., & Lin, K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12567 · Cited by 299
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Zuchero, Y. J. Y., Chen, X., Bien‐Ly, N., Bumbaca, D., Tong, R. K., Gao, X., Zhang, S., Hoyte, K., Luk, W., Huntley, M. A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.024 · Cited by 286
Raivich, G., Jones, L. L., Kloss, C. U. A., Werner, A., Neumann, H., & Kreutzberg, G. W. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05804.1998 · Cited by 273
Yoo, S. I., Yang, M., Brender, J., Vivekanandan, S., Sun, K., Joo, N. E., Jeong, S., Ramamoorthy, A., & Kotov, N. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007824 · Cited by 268
Multispecific drugs herald a new era of biopharmaceutical innovation
Deshaies, R. J. (2020) · Nature · doi:10.1038/s41586-020-2168-1 · Cited by 270
Kutuzov, N., Flyvbjerg, H., & Lauritzen, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802155115 · Cited by 250
Peptide and Protein Mimetics Inhibiting Amyloid β-Peptide Aggregation
Takahashi, T., & Mihara, H. (2008) · Accounts of Chemical Research · doi:10.1021/ar8000475 · Cited by 244
Wiping Out CGRP: Potential Cardiovascular Risks
MaassenVanDenBrink, A., Meijer, J., Villalón, C. M., & Ferrari, M. D. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.06.002 · Cited by 231
Developing Therapeutic Antibodies for Neurodegenerative Disease
Yu, Y. J., & Watts, R. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0187-4 · Cited by 231
Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer’s disease
Sehlin, D., Fang, X. T., Cato, L., Antoni, G., Lannfelt, L., & Syvänen, S. (2016) · Nature Communications · doi:10.1038/ncomms10759 · Cited by 226
Occlusion and brain function: mastication as a prevention of cognitive dysfunction
Ono, Y., YAMAMOTO, T., Kubo, K., & Onozuka, M. (2010) · Journal of Oral Rehabilitation · doi:10.1111/j.1365-2842.2010.02079.x · Cited by 226
Peripheral immune system in aging and Alzheimer’s disease
Cao, W., & Zheng, H. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0284-2 · Cited by 214
Jarius, S., Franciotta, D. M., Paul, F., Ruprecht, K., Bergamaschi, R., Rommer, P. S., Reuß, R., Probst, C., Kristoferitsch, W., Wandinger, K., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-52 · Cited by 208
Li, H., Luo, Y., Derreumaux, P., & Wei, G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.09.046 · Cited by 191
Targeting microglia for the treatment of Alzheimer’s Disease
Wes, P. D., Sayed, F. A., Bard, F., & Gan, L. (2016) · Glia · doi:10.1002/glia.22988 · Cited by 185
Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies
Smith, M. W., & Gumbleton, M. (2006) · Journal of drug targeting · doi:10.1080/10611860600650086 · Cited by 192
Wilton, D. K., Mastro, K. J., Heller, M. D., Gergits, F. W., Willing, C. R., Fahey, J. B., Frouin, A., Daggett, A., Gu, X., Kim, Y. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02566-3 · Cited by 189
Biology of the blood–nerve barrier and its alteration in immune mediated neuropathies
Kanda, T. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302312 · Cited by 179
Shimizu, F., Sano, Y., Abe, M., Maeda, T., Ohtsuki, S., Terasaki, T., & Kanda, T. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22337 · Cited by 163
Graphene quantum dots for the inhibition of β amyloid aggregation
Liu, Y., Xu, L., Dai, W., Dong, H., Wen, Y., & Zhang, X. (2015) · Nanoscale · doi:10.1039/c5nr06282a · Cited by 164
New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease
Fuller, J. P., Stavenhagen, J. B., & Teeling, J. L. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00235 · Cited by 154
Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168
Sheppard, O., Coleman, M. P., & Durrant, C. S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1490-8 · Cited by 152
Peptides crossing the blood–brain barrier: some unusual observations
Kastin, A. J., Pan, W., Maness, L. M., & Banks, W. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01961-7 · Cited by 144
Antibody therapies in CNS diseases
Freskgård, P., & Urich, E. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.014 · Cited by 144
Shimizu, F., Sano, Y., Saito, K., Abe, M., Maeda, T., Haruki, H., & Kanda, T. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0626-8 · Cited by 144
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 146
Neurodegeneration Is Associated to Changes in Serum Insulin-like Growth Factors
Busiguina, S., Fernandez, A. M., Barrios, V., Clark, R., Tolbert, D. L., Berciano, J., & Torres‐Alemán, I. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0311 · Cited by 137
Zloković, B. V. (1995) · Pharmaceutical Research · doi:10.1023/a:1016254514167 · Cited by 131
Zhang, P., Hu, L., Yin, Q., Feng, L., & Li, Y. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200600t · Cited by 129
Cleek, R. L., Ting, K. C., Eskin, S. G., & Mikos, A. G. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00052-7 · Cited by 124
Brain Repair and Neuroprotection by Serum Insulin-Like Growth Factor I
Carro, E., Trejo, J. L., Núñez, Á., & Torres‐Alemán, I. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:2:153 · Cited by 122
Efflux of monoclonal antibodies from rat brain by neonatal Fc receptor, FcRn
Cooper, P. R., Ciambrone, G. J., Kliwinski, C. M., Maze, E., Johnson, L., Li, Q., Feng, Y., & Hornby, P. J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.035 · Cited by 124
CD33 in Alzheimer’s Disease – Biology, Pathogenesis, and Therapeutics: A Mini-Review
Zhao, L. (2018) · Gerontology · doi:10.1159/000492596 · Cited by 126
Poduslo, J. F., Curran, G. L., Wengenack, T. M., Malester, B., & Duff, K. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0402 · Cited by 124
Self-citationImmune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
Pearson, J. R. D., Cuzzubbo, S., McArthur, S., Durrant, L. G., Adhikaree, J., Tinsley, C. J., Pockley, A. G., & McArdle, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582106 · Cited by 118
Körner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S., & Sedgwick, J. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270822 · Cited by 117
Stanislaus, S., Hecht, R. I., Yie, J., Hager, T., Hall, M. P., Spahr, C. S., Wang, W., Weiszmann, J., Li, Y., Deng, L., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1917 · Cited by 114
Near nerve local insulin prevents conduction slowing in experimental diabetes
Singhal, A., Cheng, C., Sun, H., & Zochodne, D. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00412-5 · Cited by 114
Androgen receptor immunoreactivity in the male and female Syrian hamster brain
Wood, R. I., & Newman, S. W. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990605)39:3 · Cited by 92
Self-citationShimizu, F., Sano, Y., Tominaga, O., Maeda, T., Abe, M., & Kanda, T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.012 · Cited by 109
Progressive supranuclear palsy: Advances in diagnosis and management
Coughlin, D. G., & Litvan, I. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.04.014 · Cited by 118
Ho, T. W., McKhann, G. M., & Griffin, J. W. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.187 · Cited by 107
Saltzman, W. M., Mak, M., Mahoney, M. J., Duenas, E. T., & Cleland, J. L. (1999) · Pharmaceutical Research · doi:10.1023/a:1018824324275 · Cited by 106
Impairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice
Fullerton, S. M., Shirman, G. A., Strittmatter, W. J., & Matthew, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7631 · Cited by 117
Banks, W. A., Farr, S. A., Morley, J. E., Wolf, K. M., Geylis, V., & Steinitz, M. O. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.005 · Cited by 103
Serum Growth Factors and Neuroprotective Surveillance
Torres‐Alemán, I. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:3:153 · Cited by 104
Biology of the human blood-nerve barrier in health and disease
Ubogu, E. E. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113272 · Cited by 106
Immunotherapy for Alzheimer's disease
Dodel, R. C., Hampel, H. J., & Du, Y. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00349-1 · Cited by 102
Mukherjee, S., Fried, A., Hussaini, R., White, R., Baidoo, J., Yalamanchi, S., & Banerjee, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0792-5 · Cited by 100
Shimizu, F., Sano, Y., Haruki, H., & Kanda, T. (2011) · Diabetologia · doi:10.1007/s00125-011-2107-7 · Cited by 100
Transport and elimination of recombinant human NGF during long-term delivery to the brain
Krewson, C. E., & Saltzman, W. M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00378-2 · Cited by 99
CD98hc is a target for brain delivery of biotherapeutics
Chew, K. S., Wells, R. C., Moshkforoush, A., Chan, D., Lechtenberg, K. J., Tran, H. L., Chow, J., Kim, D. J., Robles‐Colmenares, Y., Srivastava, D. B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40681-4 · Cited by 104
Lampe, K. J., Kern, D. S., Mahoney, M. J., & Bjugstad, K. B. (2011) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.33011 · Cited by 102
Engineered antibodies: new possibilities for brain PET?
Sehlin, D., & Syvänen, S. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04426-0 · Cited by 96
Kumar, N. N., Lochhead, J. J., Pizzo, M. E., Nehra, G., Boroumand, S., Greene, G., & Thorne, R. G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.006 · Cited by 95
Towards Non Invasive Nerve Growth Factor Therapies for Alzheimer's Disease
Cattaneo, A., Capsoni, S., & Paoletti, F. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15210 · Cited by 96
Perrone, L., Mothes-Martin, E., Vignes, M., Mockel, A., Figueroa, C. M., Miquel, M., Maddelein, M., & Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900474 · Cited by 93
Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
Arguello, A., Mahon, C. S., Calvert, M., Chan, D., Dugas, J. C., Pizzo, M. E., Thomsen, E. R., Chau, R., Damo, L. A., Duque, J. N., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20211057 · Cited by 87
Poduslo, J. F., Ramakrishnan, M., Holasek, S. S., Ramı́rez-Alvarado, M., Kandimalla, K. K., Gilles, E. J., Curran, G. L., & Wengenack, T. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04591.x · Cited by 91
Self-citationTargeting Alzheimer amyloid plaques in vivo
Wengenack, T. M., Curran, G. L., & Poduslo, J. F. (2000) · Nature Biotechnology · doi:10.1038/78482 · Cited by 87
Self-citationFernandez, A. M., de la Vega, A. G., Planas, B., & Torres‐Alemán, I. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00623.x · Cited by 86
Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
Poduslo, J. F., Curran, G. L., Sanyal, B., & Selkoe, D. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0238 · Cited by 83
Self-citationInsulin rescues amyloid β-induced impairment of hippocampal long-term potentiation
Lee, C.-C., Kuo, Y.-M., Huang, C.-C., & Hsu, K.-S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.014 · Cited by 81
Identification and in vivo characterization of a brain-penetrating nanobody
Wouters, Y., Jaspers, T., Strooper, B. D., & Dewilde, M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00226-z · Cited by 82
Poduslo, J. F., Curran, G. L., Peterson, J. A., McCormick, D., Fauq, A. H., Khan, M. A., & Wengenack, T. M. (2004) · Biochemistry · doi:10.1021/bi0359574 · Cited by 79
Self-citationHigh detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
Fang, X. T., Hultqvist, G., Meier, S. R., Antoni, G., Sehlin, D., & Syvänen, S. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.10.011 · Cited by 76
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
Pitiot, A., Heuzé‐Vourc'h, N., & Sécher, T. (2022) · Antibodies · doi:10.3390/antib11030056 · Cited by 80
Ramakrishnan, M., Kandimalla, K. K., Wengenack, T. M., Howell, K. G., & Poduslo, J. F. (2009) · Biochemistry · doi:10.1021/bi900523q · Cited by 75
Self-citationCapsoni, S., Marinelli, S., Ceci, M., Vignone, D., Amato, G., Malerba, F., Paoletti, F., Meli, G., Viegi, A., Pavone, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037555 · Cited by 76
More Than Mortar: Glia as Architects of Nervous System Development and Disease
Lago‐Baldaia, I., Fernandes, V. M., & Ackerman, S. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.611269 · Cited by 74
Engineering antibody and protein therapeutics to cross the blood–brain barrier
Zhao, P., Zhang, N., & An, Z. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac028 · Cited by 75
EGFRvIII: An Oncogene with Ambiguous Role
Rutkowska, A., Stoczyńska-Fidelus, E., Janik, K., Włodarczyk, A., & Rieske, P. (2019) · Journal of Oncology · doi:10.1155/2019/1092587 · Cited by 71
The Molecular and Biophysical Characterization of the Human Blood-Nerve Barrier: Current Concepts
Ubogu, E. E. (2013) · Journal of Vascular Research · doi:10.1159/000353293 · Cited by 69
Pornnoppadol, G., Bond, L. G., Lucas, M. J., Zupancic, J. M., Kuo, Y., Zhang, B., Greineder, C. F., & Tessier, P. M. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.09.008 · Cited by 75
Weidle, U. H., Niewöhner, J., & Tiefenthaler, G. (2015) · PubMed · Cited by 68
Pathophysiological Changes of Physical Barriers of Peripheral Nerves After Injury
Liu, Q., Wang, X., & Yi, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00597 · Cited by 69
Jungner, M., Grände, P., Mattiasson, G., & Bentzer, P. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d94d6e · Cited by 67
Metadata
- Authors
- Poduslo, J. F., Curran, G. L., & Berg, C. T.
- Affiliations
- Mayo Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5705-5709
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44065
- OpenAlex
- W2071079524
- Cited by
- 377
- References
- 82
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 18 · 2023: 24 · 2022: 16 · 2021: 16 · 2020: 32 · 2019: 16 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 12 · 2012: 19
- FWCI
- 6.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- blood-nerve barrier, blood-brain barrier, macromolecule permeability, protein permeability, insulin, nerve growth factor, transferrin, IgG, albumin, permeability coefficient, brain regions, brainstem, ventricular fluid, radioiodinated proteins, rats
- MeSH terms
- Albumins, Animals, Blood-Brain Barrier, Brain, Endocytosis, Insulin, Male, Metabolic Clearance Rate, Nerve Growth Factors, Permeability, Transferrin, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review